<bill session="115" type="h" number="5473" updated="2019-04-18T16:21:47Z">
  <state datetime="2018-06-12T14:36:54-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2018-06-12T14:36:54-04:00"/>
  </status>
  <introduced datetime="2018-04-11"/>
  <titles>
    <title type="official" as="introduced">To direct the Secretary of Health and Human Services to update or issue one or more guidances addressing alternative methods for data collection on opioid sparing and inclusion of such data in product labeling, and for other purposes.</title>
    <title type="short" as="passed house">Better Pain Management Through Better Data Act of 2018</title>
    <title type="short" as="passed house">Better Pain Management Through Better Data Act of 2018</title>
    <title type="short" as="introduced">Better Pain Management Through Better Data Act of 2018</title>
    <title type="short" as="introduced">Better Pain Management Through Better Data Act of 2018</title>
    <title type="display">Better Pain Management Through Better Data Act of 2018</title>
  </titles>
  <sponsor bioguide_id="C001105"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2018-05-09"/>
    <cosponsor bioguide_id="K000389" joined="2018-04-16"/>
    <cosponsor bioguide_id="K000381" joined="2018-06-12"/>
    <cosponsor bioguide_id="L000570" joined="2018-04-11"/>
    <cosponsor bioguide_id="M001180" joined="2018-04-12"/>
    <cosponsor bioguide_id="W000791" joined="2018-05-23"/>
  </cosponsors>
  <actions>
    <action datetime="2018-04-11">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-04-11" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2018-05-09">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2018-05-09" state="REPORTED">
      <text>Ordered to be Reported by Voice Vote.</text>
    </calendar>
    <action datetime="2018-06-12T14:29:16-04:00">
      <text>Mr. Walden moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2018-06-12T14:30:00-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H5031-5032" label="consideration"/>
    </action>
    <action datetime="2018-06-12T14:30:01-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 5473.</text>
    </action>
    <vote how="by voice vote" type="vote" datetime="2018-06-12T14:36:54-04:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.</text>
      <reference ref="CR H5031-5032" label="text"/>
    </vote>
    <action datetime="2018-06-12T14:36:55-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2018-06-13">
      <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Markup, Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Consumer affairs"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Health information and medical records"/>
    <term name="Prescription drugs"/>
    <term name="Public participation and lobbying"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
